Abstract
A new method is presented for the determination of five selected β-receptor antagonists by HPLC, which emphasizes sample preparation via retention on a new type of silica gel sorbent used for solid-phase extraction (SPE). Sorbents of this type were obtained by the chemical modification of silica gels of various porosities by cholesterol ligands. The cholesterol-based packing material was investigated by spectroscopic methods and elemental analysis. The recoveries obtained with the extraction procedure were optimum over a relatively broad sample pH range (3.08–7.50). Analytical factors such as the sample loading, the washing step and elution conditions, the concentration of β-receptor antagonists to be extracted, and the type of sorbent were found to play significant roles in the sample preparation procedure and would therefore need to be controlled to achieve optimum recoveries of the analytes. Under optimum conditions, the recoveries of nadolol, acebutolol, esmolol, oxprenolol and propranolol from spiked buffers, blood and urine were reproducible and dependent on the polarity or hydrophilicity of the compounds. The above analytes were determined by reverse-phase high-performance liquid chromatography (HPLC) with UV and ESI-ion trap mass spectrometry (MS) detection. The described method was found to be suitable for the routine measurement of compounds that are both polar and basic, and can be applied for the analysis of biological samples such as urine and blood in clinical, toxicological or forensic laboratories. The recovery measurements were performed on spiked human urine and serum, and on real samples of mouse blood serum.
Similar content being viewed by others
References
Reynolds JEF (1989) Martindale: the extra pharmacopoeia, 29th edn. Pharmaceutical Press, London
Scribiane A (1980) Pharmacology of antihypertensive drugs. Raven, New York, p 179
Ceniceros C, Maguregui MI, Jimenez RM, Alonso RM (1998) J Chromatogr B 705:97–103
Ruiz-Angel MJ, Torres-Lapasio JR, Carda-Broch S, Garcia-Alvarez-Coque MC (2003) J Chromatogr Sci 41:350–358
Sioufi A, Colussi D, Mangoni P (1983) J Chromatogr 278:185–191
Alebic-Kolbah T, Plavsic F, Wolf-Coporda A (1989) J Pharm Biomed Anal 7:1777–1784
Miller RB (1992) J Liquid Chromatogr 15:3233–3245
Herring VL, Johnson JA (1993) J Chromatogr 612:215–221
Ghanem R, Bello MA, Callejon M, Guiraum A (1996) J Pharm Biomed Anal 15:383–388
Ceniceros C, Maguregui MI, Jimenez RM, Alonso RM (1998) J Chromatogr B 705:97–103
Lant MS, Oxford J (1987) J Chromatogr 394:223–230
Ternes TA, Hirsch R, Mueller J, Haberer K (1998) Fresenius J Anal Chem 362:329–335
Johnson R, Lewis R (2006) Forensic Sci Int 156:106–117
Maurer HH, Tenberken O, Kratzsch C, Weber AA, Peters FT (2004) J Chromatogr A 1058:169–181
Albers S, Elshoff JP, Völker C, Richter A, Läer S (2005) Biomed Chromatogr 19:202–207
Stevenson D (1999) Trends Anal Chem 18:154–158
Martin P, Wilson ID, Morgan ED, Jones GR, Jones K (1997) Anal Commun 34:45–47
Olsen J, Martin P, Wilson ID, Jones GR (1999) Analyst 124:467–471
Taylor J, Sherman PL (1979) J Liq Chromatogr 2:1271–1274
Delaurent C, Tomao V, Siouffi AM (1997) Chromatographia 45:355–363
Buszewski B, Jezierska M, Wełniak M, Kaliszan R (1999) J Chromatogr A 845:433–445
Buszewski B, Welerowicz T (2004) Comb Chem High T Scr 7:291–312
Welerowicz T, Buszewski B (2005) Biomed Chromatogr 19:725–736
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Buszewski, B., Welerowicz, T., Tęgowska, E. et al. Determination of selected β-receptor antagonists in biological samples by solid-phase extraction with cholesterolic phase and LC/MS. Anal Bioanal Chem 393, 263–272 (2009). https://doi.org/10.1007/s00216-008-2369-1
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00216-008-2369-1